Clinical Research Directory
Browse clinical research sites, groups, and studies.
Spanish Registry of Cardioneuroablation
Sponsor: Fundación de investigación HM
Summary
Spanish multicenter registry of cardioneuroablation (ablation of cardiac ganglionated plexi) in patients with reflex syncope and functional bradyarrhythmias Background Cardioneuroablation (CNA) is the catheter ablation of the ganglionated plexi (GP) of the intrinsic cardiac autonomic nervous system, located in the atrial epicardial fat, to reduce parasympathetic tone on the sinus node and the atrioventricular (AV) node. It has been proposed as an alternative to pacemaker implantation in patients, often young, with cardioinhibitory reflex syncope or vagally mediated bradyarrhythmias. However, the available evidence comes mainly from single-center series at highly experienced centers, with heterogeneous techniques (choice of atrium, number of GP targeted, localization method, type of anesthesia) and no standardized acute procedural endpoint. Data from real-world clinical practice are needed to define its efficacy and safety, and to identify which patients and which procedural strategies are associated with better outcomes. Objectives Primary: to assess syncope recurrence after CNA in real-world clinical practice in Spain. Secondary: 1) to describe the procedural characteristics and complications of CNA; 2) to identify clinical and procedural predictors of success; 3) to evaluate the change in syncope and presyncope burden and the need for pacemaker implantation during follow-up. Design Observational, multicenter, ambispective, ongoing registry with 27 participating hospitals in Spain. Cases performed since June 2018 are collected retrospectively, and prospective enrollment of consecutive patients has been in place since April 2021. Study population Inclusion criteria: consecutive patients undergoing CNA for syncope with one of the following phenotypes: * Cardioinhibitory reflex syncope: bradycardia \<40 bpm or asystole documented on tilt testing, Holter monitoring or implantable loop recorder. * Mixed reflex syncope: blood pressure drop preceding the heart rate drop on tilt testing. * Functional sinus node dysfunction. * Functional AV block. Procedure CNA is performed according to the usual practice of each center. The operator chooses: * the approach (right atrium, left atrium or both); * the number of GP targeted; * the GP localization method (anatomical, fragmented electrograms, high-frequency stimulation, extracardiac vagal stimulation or combinations); * the type of anesthesia (general anesthesia, deep sedation, conscious sedation). Data collected * Baseline: demographics, body mass index, cardiovascular history and structural heart disease, type of syncope, number of syncopal and presyncopal episodes before CNA, and diagnostic tests (tilt testing, Holter, implantable loop recorder, atropine test). * Procedural: approach, GP targeted, localization method, type of anesthesia, ablation catheter and navigation system, RF power and number of applications, procedure and fluoroscopy times, heart rate before and after CNA and response to atropine after the procedure. * Safety: procedure-related complications, including sinus node dysfunction, inappropriate sinus tachycardia and vascular complications. * Follow-up: syncope and presyncope recurrence, number of episodes per year, need for pacemaker implantation and other clinical events. Endpoints Primary endpoint: first syncope recurrence after CNA. Secondary endpoints: procedure-related complications; number of syncopal and presyncopal episodes per year before and after CNA; pacemaker implantation during follow-up. Ongoing sub-studies: 1. long-term follow-up of these patients and identification of predictors of recurrence; 2. redo procedures, in patients requiring more than one CNA; 3. patients followed with an implantable loop recorder (subcutaneous Holter). Expected relevance This registry will provide multicenter real-world data on CNA in Spain. It will help to identify the patients most likely to benefit from the procedure and the technical aspects associated with success, and will generate hypotheses for future randomized trials.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
400
Start Date
2018-06-01
Completion Date
2031-12-31
Last Updated
2026-11-17
Healthy Volunteers
No
Interventions
cardioneuroablation
cardioneuroablation
Locations (27)
Hospital HM Monteprincipe
Madrid, Madrid, Spain
Hospital La Paz
Madrid, Madrid, Spain
Hospital Albacete
Albacete, Spain
Hospital General Alicante
Alicante, Spain
Hospital Badajoz
Badajoz, Spain
Hospital Dexeus Barcelona
Barcelona, Spain
Hospital Vall d´Hebron
Barcelona, Spain
Hospital de Basurto
Bilbao, Spain
Hospital Reina Sofia
Córdoba, Spain
Hospital Josep Trueta
Girona, Spain
Hospital Clinico Granada
Granada, Spain
Hospital Virgen de las Nieves
Granada, Spain
Hospital Juan Ramón Jiménez
Huelva, Spain
Hospital 12 de Octubre
Madrid, Spain
Hospital Fundación Jiménez Díaz
Madrid, Spain
Hospital Gregorio Marañon
Madrid, Spain
Hospital Puerta de Hierro
Madrid, Spain
Hospital Ramón y Cajal
Madrid, Spain
Hospital Torrejon
Madrid, Spain
Hospital Universitario de Navarra
Navarro, Spain
Hospital Valdecilla
Santander, Spain
Hospital Santiago de Compostela
Santiago de Compostela, Spain
Hospital La Fe
Valencia, Spain
Hospital Valladolid
Valladolid, Spain
Hospital Álvaro Cunqueiro
Vigo, Spain
Hospital Txagorritxu
Vitoria-Gasteiz, Spain
Hospital Miguel Servet
Zaragoza, Spain